Lab Haz Waste Management Manual Table of Contents > Environmental Health and Safety > Resources > Lab Haz Waste Management Manual Table of Contents: UNIVERSITY of TORONTO Laboratory Hazardous Waste Management and Disposal. Manual tasks (or manual handling) are specifically covered by Part 4.2 – Hazardous Manual Tasks – of the model. Definition of 'Manual Handling'. Definition Of Hazardous Manual Handling What is clear is that a load may meet the definition of hazardous manual handling despite being particularly light – as in.
OSHA Technical Manual (OTM) | Section VI: Chapter 2. C. Work Equipment. NIH has recommended that work with HD's be carried out in a BSC on a disposable, plastic- backed paper liner.
The liner should be changed after preparation is completed for the day or after a shift, whichever comes first. Liners should also be changed after a spill. Syringes and IV sets with Luer- lock fittings should be used for HD's.
Syringe size should be large enough so that they are not full when the entire drug dose is present. A covered disposable container should be used to contain excess solution. A covered sharps container should be in the BSC. The ASHP recommends that HD- labeled plastic bags be available for all contaminated materials (including gloves, gowns, and paper liners), so that contaminated material can be immediately placed in them and disposed of in accordance with ASHP recommendations. Workers who are potentially exposed to chemical hazards should be monitored in a systematic program of medical surveillance intended to prevent occupational injury and disease. The purpose of surveillance is to identify the earliest reversible biologic effects so that exposure can be reduced or eliminated before the employee sustains irreversible damage.
The occurrence of exposure- related disease or other adverse health effects should prompt immediate re- evaluation of primary preventive measures (e. In this manner, medical surveillance acts as a check on the appropriateness of controls already in use. For detection and control of work- related health effects, job- specific medical evaluations should be performed, as follows: This information should be collected and analyzed in a systematic fashion to allow early detection of disease patterns in individual workers and groups of workers.
Recognized occupational medicine experts in the HD area recommend these exams to update the employee's medical, reproductive, and exposure histories. They are recommended on a yearly basis or every two to three years. The interval between exams is a function of the opportunity for exposure, duration of exposure, and possibly the age of the worker at the discretion of the occupational medicine physician, guided by the worker's history. Careful documentation of an individual's routine exposure and any acute accidental exposures are made.
The physical examination and laboratory studies follow the format outlined in the preplacement examination. Postexposure evaluation is tailored to the type of exposure (e. HD's). An assessment of the extent of exposure is made and included in the confidential database (discussed below) and in an incident report. The physical examination focuses on the involved area as well as other organ systems commonly affected (i. CD's the skin and mucous membranes; for aerosolized HD's the pulmonary system).
Connecticut’s Commercial Driver’s Manual Hazardous Materials Section Booklet Dannel P. Malloy Governor Melody A. Currey Commissioner Prepared by: State of Connecticut Department of Motor Vehicles 60 State Street.
Definition Hazardous Manual Tasks The Code of Practice for Hazardous Manual Tasks has been developed to explain how to identify hazardous manual tasks, assess the. MANUAL HANDLING - Safety Policy and Guidance 1. General Statement This policy sets out Birkbeck's arrangements to comply with the Manual Handling Operations Regulations 1992 (as amended). All managers have a responsibility to. Hazardous manual tasks. Physical hazards include a variety of manual tasks that you do in your everyday. Ensure staff are trained in manual handling techniques.
Treatment and laboratory studies follow as indicated and should be guided by emergency protocols. The exit examination completes the information on the employee's medical, reproductive and exposure histories.
Examination and laboratory evaluation should be guided by the individual's history of exposures and follow the outline of the periodic evaluation. Exposure assessment of all employees who have worked with HD's is important, and the maintenance of records is required by 2. CFR 1. 91. 0. 1. 02. The use of previously outlined exposure surrogates is acceptable, although actual environmental or employee monitoring data is preferable. An MSDS can serve as an exposure record. Details of the use of personal protective equipment and engineering controls present should be included. A confidential database should be maintained with information regarding the individual's medical and reproductive history, with linkage to exposure information to facilitate epidemiologic review.
The examining physician should consider the reproductive status of employees and inform them regarding relevant reproductive issues. The reproductive toxicity of hazardous drugs should be carefully explained to all workers who will be exposed to these chemicals, and is required for those chemicals covered by the HCS. Unfortunately, no information is available regarding the reproductive risks of HD handling with the current use of BSC's and PPE.
However, as discussed earlier, both spontaneous abortion and congenital malformation excesses have been documented among workers handling some of these drugs without currently recommended engineering controls and precautions. The facility should have a policy regarding reproductive toxicity of HD's and worker exposure in male and female employees and should follow that policy. This paragraph is for informational purposes only and is not a substitute for the requirements of the Hazard Communication Standard.
In accordance with requirements in the Hazard Communication Standard, the employer must maintain MSDS's accessible to employees for all covered HD's used in the hospital. Specifics regarding MSDS content are contained in the Standard. Essential information includes: health hazards, primary exposure routes, carcinogenic evaluations, acute exposure treatment, chemical inactivators, solubility, stability, volatility, PPE required, and spill procedures for each covered HD. MSDS's shall also be made readily available upon request to employees, their designated representatives, or the Assistant Secretary of OSHA. Employees must be informed of the requirements of the Hazard Communication Standard, 2.
CFR 1. 91. 0. 1. 20. C. Employee Training.
Employee training must include at least the following elements. Methods and observations that may be used to detect the presence or release of an HCS- covered hazardous drug in the work area (such as monitoring conducted by the employer, continuous monitoring devices, visual appearance or odor of covered HD's being released, etc.).
The physical and health hazards of the covered HD's in the work area. The measures employees can take to protect themselves from these hazards.
This includes specific procedures that the employer has implemented to protect the employees from exposure to such drugs, such as identification of covered drugs and those to be handled as hazardous, appropriate work practices, emergency procedures (for spills or employee exposure). Personal protective equipment, and the details of the hazard communication program developed by the employer, including an explanation of the labeling system and the MSDS, and how employees can obtain and use the appropriate hazard information. It is essential that workers understand the carcinogenic potential and reproductive hazards of these drugs. Both females and males should understand the importance of avoiding exposure, especially early in pregnancy, to the drugs, so that they can make informed decisions about the hazards involved. In addition, the facility's policy regarding reproductive toxicity of HD's should be explained to workers. Updated information should be provided to employees on a regular basis and whenever their jobs involve new hazards. Medical staff and other personnel who are not hospital employees should be informed of hospital policies and of the expectation that they will comply with these policies.
IX. Recordkeeping. Any workplace exposure record created in connection with HD handling shall be kept, transferred, and made available for at least 3. Access to Employee Exposure and Medical Records Standard (2. CFR 1. 91. 0. 1. 02. In addition, sound practice dictates that training records should include the following information: Dates of the training sessions; Contents or a summary of the training sessions; Names and qualifications of the persons conducting the training; and.
Names and job titles of all persons attending the training sessions. Training records should be maintained for three years from the date on which the training occurred. X. References. 1.
American Medical Association Council on Scientific Affairs. Guidelines for handling parenteral antineoplastics." J.
A. M. A. 2. 53: 1. American National Standards Institute. Occupational and Educational Eye and Face Protection. ANSI Z8. 7. 1. 3.
American Society of Hospital Pharmacists. ASHP Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs. Am. J. Hosp. Pharm. Andersen, R., Boedicker, M., Ma, M., and Goldstein, E. J. C. 1. 98. 6. "Adverse Reactions Associated with Pentamidine Isethionate in AIDS Patients: Recommendations for Monitoring Therapy." Drug Intell. Clin. Pharm. 2. 0: 8.
Anderson, R. W., Puckett, W. H., Dana, W. J., et al. Risk of handling injectable antineoplastic agents." Am. J. Hosp. Pharm. 3. Avis, K. E., and Levchuck, J.
W. 1. 98. 4. "Special considerations in the use of vertical laminar flow workbenches." Am. J. Hosp. Pharm. 4. Barber, R. K. 1. 98. Fetal and neonatal effects of cytotoxic agents." Obstet. Gynecol. 5. 1: 4. S- 4. 7S. 8. Benhamou, S., Pot- Deprun, J., Sancho- Garnier, H., and Chouroulinkov, I. Sister chromatid exchanges and chromosomal aberrations in lymphocytes of nurses handling cytostatic drugs." I 4.
Bos, R. P., Leenars, A. O., Theuws, J. L., and Henderson, P. T. 1. 98. 2. "Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking." Int. Arch. Occ. Envir.
Health 5. 0: 3. 59- 6. Bryan, D., and Marback, R. C. 1. 98. 4. "Laminar- airflow equipment certification: What the pharmacist needs to know." Am. J. Hosp. Pharm. 4.
Burgaz, S., Ozdamar, Y. N., and Karakaya, A. E. 1. 98. 8. "A signal assay for the detection of genotoxic compounds: Application on the urine of cancer patients on chemotherapy and of nurses handling cytotoxic drugs." Human Toxicol. California Department of Health Services Occupational Health Surveillance and Evaluation Program. Health care worker exposure to ribavirin aerosol: field investigation Fl- 8. Berkeley: California Department of Health Services. Castegnaro, M., Adams, J., Armour, M.
A., et al., eds. 1. Laboratory decontamination and destruction of carcinogens in laboratory wastes: Some antineoplastic agents. International Agency for Research on Cancer.